Showing 241-250 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Targeting type 1 Diabetes through Polyamines with DFMO Trustees of Indiana University Emily Sims Cures 01-October-2022 to 30-September-2026 $3,693,701.00
Investigating Combinatorial Use of Inhibitors of Focal Adhesion Kinase and PFKFB3 for Reversal of Type 1 Diabetes Trustees of Indiana University Jon Piganelli Cures 01-August-2023 to 30-June-2025 $334,595.29
SOLUBLE LYMPHOCYTE ACTIVATION GENE-3 (s-LAG-3): A POTENTIAL SURROGATE MARKER FOR TYPE-1 DIABETES PROGRESSION AND IMMUNOTHERAPY SUCCESS Trustees of Indiana University Jon Piganelli Cures 01-July-2025 to 30-June-2026 $153,000.00
CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes Trustees of Indiana University Viral Shah Cures 01-November-2024 to 31-October-2027 $900,000.00
Relationship of Time-In-Range with microvascular complications in type 1 diabetes Trustees of Indiana University Viral Shah Improving Lives 01-February-2024 to 31-July-2025 $71,123.95
Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: multicenter, registry-based study Trustees of Indiana University Viral Shah Improving Lives 01-September-2025 to 31-August-2028 $1,603,777.39
Pancreatic Lymph Node T cell Composition and Function in Human Type 1 Diabetes Trustees of the University of Pennsylvania Gregory Golden Cures 01-April-2023 to 31-March-2026 $214,356.00
Evaluating gene-modified hypo-immune PSCs for immune evasion in NHPs Trustees of the University of Pennsylvania Ji Lei Cures 01-June-2025 to 31-May-2027 $749,999.08
An AI-driven bioelectronics system to accelerate SC-islet maturation Trustees of the University of Pennsylvania Juan Alvarez Cures 01-April-2025 to 31-March-2026 $200,000.00
T1 TRIDENT / Transformative Research in Diabetic Nephropathy Trustees of the University of Pennsylvania Katalin Susztak Improving Lives 01-September-2019 to 30-September-2024 $191,795.06